E infα supk transgene in B10 mice suppresses the development of myasthenia gravis

P Christadoss, CS David, M Shenoy, S Keve - Immunogenetics, 1990 - Springer
P Christadoss, CS David, M Shenoy, S Keve
Immunogenetics, 1990Springer
Mice bearing the H-2 b haplotype are susceptible to the development of experimental
autoimmune myasthenia gravis (EAMG), induced by acetylcholine receptor (AChR)
autoimmunity. One of the genes influencing EAMG susceptibility has been mapped to the A
b locus of the major histocompatibility complex, and the Aβ chain has been implicated in the
pathogenesis. Mice of the H-2 b haplotype, including C57BL/10 (B10), have a genomic
deletion of the E α gene and therefore fail to express the E molecule on their cell surface. To …
Abstract
Mice bearing the H-2 bhaplotype are susceptible to the development of experimental autoimmune myasthenia gravis (EAMG), induced by acetylcholine receptor (AChR) autoimmunity. One of the genes influencing EAMG susceptibility has been mapped to the A blocus of the major histocompatibility complex, and the Aβ chain has been implicated in the pathogenesis. Mice of the H-2 bhaplotype, including C57BL/10 (B10), have a genomic deletion of the E αgene and therefore fail to express the E molecule on their cell surface. To test the hypothesis that failure to express the cell surface E molecule in B10 mice contributes to EAMG pathogenesis, E infα supk transgenic B10 mice expressing the T molecule were examined. Expression of the E molecule in E infα supk transgenic B10 mice partially prevented the development of EAMG.
Springer